Literature DB >> 25593272

Targeting microRNAs to limit myocardial lipid accumulation.

Gary D Lopaschuk1, John R Ussher2.   

Abstract

Entities:  

Keywords:  AMP-activated protein kinases; Editorials; cardiomyopathies; ceramides; heart; microRNA; obesity

Mesh：

Substances：

Year:  2015        PMID： 25593272     DOI： 10.1161/CIRCRESAHA.114.305675

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  3 in total

Review 1.  MicroRNAs in Obesity-Associated Disorders: The Role of Exercise Training.

Authors:  Andre Silveira; João Gomes; Fernanda Roque; Tiago Fernandes; Edilamar Menezes de Oliveira
Journal:  Obes Facts       Date:  2022-01-20       Impact factor: 4.807

2.  Serum microRNA-1 and microRNA-133a levels reflect myocardial steatosis in uncomplicated type 2 diabetes.

Authors:  D de Gonzalo-Calvo; R W van der Meer; L J Rijzewijk; J W A Smit; E Revuelta-Lopez; L Nasarre; J C Escola-Gil; H J Lamb; V Llorente-Cortes
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

3.  Time course of cardiometabolic alterations in a high fat high sucrose diet mice model and improvement after GLP-1 analog treatment using multimodal cardiovascular magnetic resonance.

Authors:  Inès Abdesselam; Pauline Pepino; Thomas Troalen; Michael Macia; Patricia Ancel; Brice Masi; Natacha Fourny; Bénédicte Gaborit; Benoît Giannesini; Frank Kober; Anne Dutour; Monique Bernard
Journal:  J Cardiovasc Magn Reson       Date:  2015-11-06       Impact factor: 5.364
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.